Cite

HARVARD Citation

    Terlizzi, V. et al. (2021). Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype. Molecular genetics & genomic medicine. 9 (4), p. n/a. [Online]. 
  
Back to record